- Home
- YHGJ vs CDIO Comparison
YHGJ vs CDIO Comparison
Compare YHGJ & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- CDIO
- Stock Information
- Founded
- YHGJ 1975
- CDIO 2017
- Country
- YHGJ United States
- CDIO United States
- Employees
- YHGJ N/A
- CDIO N/A
- Industry
- YHGJ Specialty Chemicals
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- YHGJ Industrials
- CDIO Health Care
- Exchange
- YHGJ Nasdaq
- CDIO Nasdaq
- Market Cap
- YHGJ 14.0M
- CDIO 20.2M
- IPO Year
- YHGJ 1997
- CDIO N/A
- Fundamental
- Price
- YHGJ $0.60
- CDIO $0.47
- Analyst Decision
- YHGJ
- CDIO Buy
- Analyst Count
- YHGJ 0
- CDIO 1
- Target Price
- YHGJ N/A
- CDIO $2.00
- AVG Volume (30 Days)
- YHGJ 231.9K
- CDIO 3.9M
- Earning Date
- YHGJ 02-19-2025
- CDIO 11-13-2024
- Dividend Yield
- YHGJ N/A
- CDIO N/A
- EPS Growth
- YHGJ N/A
- CDIO N/A
- EPS
- YHGJ N/A
- CDIO N/A
- Revenue
- YHGJ $18,559,000.00
- CDIO $35,688.00
- Revenue This Year
- YHGJ N/A
- CDIO $228.74
- Revenue Next Year
- YHGJ N/A
- CDIO $854.55
- P/E Ratio
- YHGJ N/A
- CDIO N/A
- Revenue Growth
- YHGJ 11.78
- CDIO 180.90
- 52 Week Low
- YHGJ $0.43
- CDIO $0.19
- 52 Week High
- YHGJ $1.85
- CDIO $2.05
- Technical
- Relative Strength Index (RSI)
- YHGJ 51.40
- CDIO 40.08
- Support Level
- YHGJ $0.52
- CDIO $0.42
- Resistance Level
- YHGJ $0.76
- CDIO $0.47
- Average True Range (ATR)
- YHGJ 0.11
- CDIO 0.07
- MACD
- YHGJ 0.01
- CDIO -0.01
- Stochastic Oscillator
- YHGJ 14.40
- CDIO 21.06
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.